The start of trials is a milestone for Bayer's ambition to develop cell and gene-based therapies for Parkinson's that could replace the dopamine-producing neurons in the midbrain area that are ...

Bayer Leverkusen’s Alejandro Grimaldo has made it clear that he has always dreamed of playing for Barcelona. In an interview ...